From Resilience to Vulnerability: How Stress Accelerates Aging
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
University Of California, Irvine
Irvine, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$182,000
Active Dates
July 01, 2025 - June 30, 2027
Grant ID
G2025009S
Co-Principal Investigator(s)
Qing Nie, PhD, The Regents of the University of California, Irvine
Goals
This project investigates how repeated mild stress alters gene expression and epigenetic patterns, accelerating aging in the retina and increasing vulnerability to neurodegeneration.
Summary
Aging, a process where damage accumulates in our cells over time, makes tissues more sensitive to elevated intraocular pressure (IOP). However, it is unknown how cells become more vulnerable as they age. Our experiments will explore how retinas respond to IOP-related stress and the mechanisms behind this vulnerability, aiming to find new ways to protect retinal neurons from glaucomatous changes.
Unique and Innovative
This project uniquely models accelerated aging using controlled, mild stress in young tissue. By linking progressive epigenetic changes to loss of resilience, it introduces a stepwise framework for aging. The integration of transcriptomic and epigenomic data to define early-to-late stage transitions in neuronal aging is novel and could reveal therapeutic targets to restore resilience.
Foreseeable Benefits
By revealing how repeated mild stress accelerates aging, this study could lead to early diagnostic markers and interventions that preserve eye function with age. Understanding the stepwise epigenetic changes from resilience to vulnerability may inform treatments for neurodegenerative diseases. Ultimately, this research could benefit both the aging population and scientific efforts to delay or reverse age-related neurodegenerative diseases like glaucoma.
Related Grants
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
National Glaucoma Research
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine